Editorial
Published on 08 Dec 2022
Editorial: Nanomaterials and multimodal tumor therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1081687
- 1,922 views
- 6 citations
Type at least 3 characters
1,074 articles
Original Research
Published on 06 Dec 2022
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1028871
- 2,213 views
- 6 citations
Brief Research Report
Published on 01 Dec 2022
Microenvironmental changes co-occur with mosaic somatic clonal expansions in normal skin and esophagus tissues
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1021940
- 1,442 views
- 1 citation
Mini Review
Published on 29 Nov 2022
KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1013902
- 34,371 views
- 64 citations
Mini Review
Published on 24 Nov 2022
Targeting autophagy in pancreatic cancer: The cancer stem cell perspective
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1049436
- 4,638 views
- 6 citations
Original Research
Published on 23 Nov 2022
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1005626
- 4,164 views
- 20 citations
Original Research
Published on 15 Nov 2022
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1026251
- 4,033 views
- 17 citations
Review
Published on 15 Nov 2022
Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.988956
- 5,152 views
- 8 citations
Review
Published on 15 Nov 2022
A bibliometric and visualization-based analysis of temozolomide research hotspots and frontier evolution
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.905868
- 3,377 views
- 2 citations
Brief Research Report
Published on 10 Nov 2022
Therapeutic drug monitoring in oncology - What’s out there: A bibliometric evaluation on the topic
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.959741
- 5,525 views
- 6 citations
Original Research
Published on 10 Nov 2022
Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells via an inhibition of CaMKII/CREB1 mediated ABCB1 expression
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1068443
- 3,055 views
- 5 citations
Original Research
Published on 03 Nov 2022
Mediating effect assessment of ifosfamide on limb salvage rate in osteosarcoma: A study from a single center in China
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1046199
- 2,183 views
- 1 citation
Systematic Review
Published on 03 Nov 2022
Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue sarcoma, ovarian carcinoma, and endometrial carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.914342
- 8,314 views
- 15 citations
Original Research
Published on 02 Nov 2022
Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.943064
- 3,257 views
- 6 citations
Original Research
Published on 01 Nov 2022
Activity and safety of apatinib monotherapy or apatinib combined with chemotherapy for patients with metastatic or unresectable osteosarcoma over the age of 40 years: A retrospective analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1031787
- 1,710 views
- 1 citation
Editorial
Published on 01 Nov 2022
Editorial: The effects of chemotherapy towards the tumor microenvironment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1069561
- 1,773 views
- 2 citations